1 Super Stock Down More Than 20% to Buy Hand Over Fist, According to Wall Street

The positives for this big drugmaker appear to outweigh the negatives.For a while, it seemed that nothing could go wrong for Eli Lilly (LLY 0.23%). Surging sales for Lilly's type 2 diabetes drug Mounjaro and great expectations for its obesity drug Zepbound fueled massive gains for the pharma stock.Along the way, Lilly became the largest healthcare company on the planet based on market cap. However, the story hasn't been so great for the drugmaker since last summer. Its share price remains more than 20% belo ...